Literature DB >> 10854254

The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis.

H Zhu1, W Fu, M P Mattson.   

Abstract

The catalytic subunit of telomerase (TERT) is a specialized reverse transcriptase that has been associated with cell immortalization and cancer. It was reported recently that TERT is expressed in neurons throughout the brain in embryonic and early postnatal development, but is absent from neurons in the adult brain. We now report that suppression of TERT levels and function in embryonic mouse hippocampal neurons in culture using antisense technology and the telomerase inhibitor 3' -azido-2' 3' -dideoxythymidine significantly increases their vulnerability to cell death induced by amyloid beta-peptide, a neurotoxic protein believed to promote neuronal degeneration in Alzheimer's disease. Neurons in which TERT levels were reduced exhibited increased levels of oxidative stress and mitochondrial dysfunction following exposure to amyloid beta-peptide. Overexpression of TERT in pheochromocytoma cells resulted in decreased vulnerability to amyloid beta-peptide-induced apoptosis. Our findings demonstrate a neuroprotective function of TERT in an experimental model relevant to Alzheimer's disease, and suggest the possibility that restoration of TERT expression in neurons in the adult brain may protect against age-related neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854254     DOI: 10.1046/j.1471-4159.2000.0750117.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Telomerase contributes to tumorigenesis by a telomere length-independent mechanism.

Authors:  Sheila A Stewart; William C Hahn; Benjamin F O'Connor; Elisa N Banner; Ante S Lundberg; Poonam Modha; Hana Mizuno; Mary W Brooks; Mark Fleming; Drazen B Zimonjic; Nicholas C Popescu; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

3.  Telomerase extracurricular activities.

Authors:  Sandy Chang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 4.  DNA damage responses in neural cells: Focus on the telomere.

Authors:  P Zhang; C Dilley; M P Mattson
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

5.  Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells.

Authors:  Michael Thomas; Tetsuya Suwa; Lianqing Yang; Lifang Zhao; Christina L Hawks; Peter J Hornsby
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

6.  Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase.

Authors:  Qing-You Du; Xiao-Bo Wang; Xue-Jun Chen; Wei Zheng; Sheng-Qi Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Flavanols, mild cognitive impairment, and Alzheimer's dementia.

Authors:  Ami K Patel; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2008-04-15

Review 8.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 9.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

10.  Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.

Authors:  Sascha Jakob; Peter Schroeder; Margarete Lukosz; Nicole Büchner; Ioakim Spyridopoulos; Joachim Altschmied; Judith Haendeler
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.